Skip to content

Muscle Vibration in MS to Improve Walking

Cyclical Muscle Vibration in MS to Improve Walking

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03403413
Enrollment
5
Registered
2018-01-18
Start date
2017-01-01
Completion date
2018-12-31
Last updated
2020-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Brief summary

The primary goal of this pilot study is to explore the feasibility of cyclic vibration (CV) of the lower extremity muscles to improve walking in individuals with gait deficits from multiple sclerosis (MS).

Detailed description

This pilot study is designed to test the efficacy and safety of vibration at correcting the typical gait deficits that involve strength and coordination of multiple joints (hip, knee and ankle) in pre- and early swing phases of the gait cycle. Aim 1: Develop a real-time control algorithm, timed by sensor detected gait events, to provide vibration emulating electromyographic (EMG) activity of target muscles during normal gait and verify its functionality in an able-body volunteer. Further, recruit 12 subjects (6 for CV and 6 controls) with gait deficits at the hip, knee and ankle from MS. Impose vibration during the gait cycle so that it emulates muscle activity pattern of normal gait. Perform baseline quantitative gait analyses to determine the spatio-temporal parameters, foot-to-floor clearance, kinematics, kinetics and patterns of EMG activity during walking with and without vibration in treatment group and without vibration in control group. Aim 2: Implement 12 sessions (3/week for a month) of gait training with cyclic vibration emulating normal muscle activity of lower extremities in treatment group and gait training without vibration in control group and repeat baseline gait assessment to test the following hypotheses. Hypothesis 1. Vibration of hip, knee and ankle muscles improves walking speed and foot-to-floor clearance through increased hip and knee pre-swing flexion and improved hip-knee coordination. Hypothesis 2. Gait training with cyclic muscle vibration induces carryover effects that maintain improved walking after vibration is discontinued. Hypothesis 3. Muscle vibration produces no untoward sensations or adverse physiological responses.

Interventions

DEVICEmuscle vibration during walking

Baseline assessment of gait followed by 12 sessions (3/week for a month) of gait training with cyclic muscle vibration during walking emulating normal muscle activity of lower extremities in treatment group. Gait assessment both with and without muscle vibration were collected at follow-up after 12 sessions of gait training with muscle vibration.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* MS diagnosis reviewed and confirmed by neurologist per the revised McDonald criteria \[ \] * EDDS\>3 * Age 18-70 * Fixed gait deficiency defined as being present for at least 3 months without improvement * Hip, knee and ankle muscle weakness or increased extensor tone with difficulty to initiate a step * Ability to ambulate at least 10ft with contact guard. * Muscle vibration without untoward sensation. * Sufficient upper extremity function to use walking aids (walkers, crutches, canes). * Poor hip-knee-ankle coordination during swing * Hip, knee and ankle joint range within normal limits. * Ability to clearly understand written and oral direction in English to provide consent. * BMI \< 30 * Absence of psychological and cognitive problems or chemical dependency * No acute orthopedic or medical complications

Exclusion criteria

* Presence of demand pacemakers. * Edema of the affected limb/s. * Uncontrolled seizures/epilepsy. * Severe depression. * Botulin toxin treatment within 12 months. * Peripheral neuropathy. * Respiratory disease. * Chronic pain. * Rapidly progressive course suggestive of Marburg variant, Hurst encephalomyelitis or PPMS with three or more system involvement. * Concurrent treatment with Tysabri. * Cardiac arrhythmias with associated hemodynamic instability. * Lower extremity injuries that limit range of motion or function * Joint problems (hip or leg) that limit range of motion or cause pain with movement * Women during pregnancy * Patients with a relapse in the 3 months prior to presentation for study evaluation * Patients with more than two relapses within the past 12 months

Design outcomes

Primary

MeasureTime frameDescription
10MWTbaseline and after twelve 1 hour sessions in four weeks of gait training with muscle vibration. Outcome measures were tested both with and without muscle vibration and repeated measures were collected and averaged.speed (m/s)
Kinematicsbaseline and after twelve 1 hour sessions in four weeks of gait training with muscle vibration. Repeated measures were collected and averagedPeak hip, knee and ankle flexion during swing
Toe Clearancebaseline and after twelve 1 hour sessions in four weeks of gait training with muscle vibration. Repeated measures were collected and averagedToe clearance between foot and the ground during swing
Walking Distancebaseline and after twelve 1 hour sessions in four weeks of gait training with muscle vibration. Repeated measures were collected and averagedVolitional walking distance at baseline and after gait training with vibration

Countries

United States

Participant flow

Recruitment details

3

Pre-assignment details

3

Participants by arm

ArmCount
Muscle Vibration
Test feasibility of muscle vibration of tibialis anterior, rectus femoris, short head of biceps and tensor fasciae latae bilaterally during walking for 1 hour 3 times per week for 12 weeks to improve walking speed through improved coordination of hip, knee and ankle flexion. muscle vibration during walking: Baseline assessment of gait followed by 12 sessions (3/week for a month) of gait training with cyclic muscle vibration during walking emulating normal muscle activity of lower extremities in treatment group and gait training without muscle vibration during walking in control group and repeat gait assessment after gait training.
3
Total3

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLack of Efficacy2

Baseline characteristics

CharacteristicMuscle Vibration
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
3 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
3 Participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
3 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 5
other
Total, other adverse events
0 / 5
serious
Total, serious adverse events
0 / 5

Outcome results

Primary

10MWT

speed (m/s)

Time frame: baseline and after twelve 1 hour sessions in four weeks of gait training with muscle vibration. Outcome measures were tested both with and without muscle vibration and repeated measures were collected and averaged.

Population: Multiple sclerosis

ArmMeasureGroupValue (MEAN)Dispersion
Subject A10MWTFollow-up without vibration1.295 m/sStandard Deviation 0.07
Subject A10MWTBaseline1.1 m/sStandard Deviation 0
Subject A10MWTFollow-up with vibration1.39 m/sStandard Deviation 0.05
Subject B10MWTFollow-up without vibration1.32 m/sStandard Deviation 0.009
Subject B10MWTBaseline0.75 m/sStandard Deviation 0.09
Subject B10MWTFollow-up with vibration1.38 m/sStandard Deviation 0.05
Subject C10MWTBaseline1.39 m/sStandard Deviation 0.2
Subject C10MWTFollow-up with vibration1.86 m/sStandard Deviation 0.17
Subject C10MWTFollow-up without vibration2.18 m/sStandard Deviation 0.2
Primary

Kinematics

Peak hip, knee and ankle flexion during swing

Time frame: baseline and after twelve 1 hour sessions in four weeks of gait training with muscle vibration. Repeated measures were collected and averaged

Population: Multiple sclerosis

ArmMeasureGroupValue (MEAN)Dispersion
Subject AKinematicsVolitional ankle flexion post-vibration training14 degreesStandard Deviation 2.8
Subject AKinematicsVolitional knee flexion pre-training49 degreesStandard Deviation 2.4
Subject AKinematicsVolitional ankle dorsiflexion pre-training11 degreesStandard Deviation 2.7
Subject AKinematicsVolitional hip flexion pre-training24 degreesStandard Deviation 2.4
Subject AKinematicsVolitional knee flexion post-vibration training61 degreesStandard Deviation 3.4
Subject AKinematicsVolitional hip flexion post-vibration training38 degreesStandard Deviation 1.9
Subject BKinematicsVolitional knee flexion post-vibration training44 degreesStandard Deviation 15.8
Subject BKinematicsVolitional ankle dorsiflexion pre-training13 degreesStandard Deviation 4.5
Subject BKinematicsVolitional hip flexion post-vibration training50 degreesStandard Deviation 5.8
Subject BKinematicsVolitional ankle flexion post-vibration training11 degreesStandard Deviation 3.2
Subject BKinematicsVolitional hip flexion pre-training57 degreesStandard Deviation 7.4
Subject BKinematicsVolitional knee flexion pre-training38 degreesStandard Deviation 16.3
Subject CKinematicsVolitional ankle flexion post-vibration training15 degreesStandard Deviation 5.2
Subject CKinematicsVolitional hip flexion pre-training27 degreesStandard Deviation 2.3
Subject CKinematicsVolitional hip flexion post-vibration training30 degreesStandard Deviation 2.5
Subject CKinematicsVolitional knee flexion pre-training72 degreesStandard Deviation 3.5
Subject CKinematicsVolitional knee flexion post-vibration training74 degreesStandard Deviation 2.5
Subject CKinematicsVolitional ankle dorsiflexion pre-training15 degreesStandard Deviation 4
Primary

Toe Clearance

Toe clearance between foot and the ground during swing

Time frame: baseline and after twelve 1 hour sessions in four weeks of gait training with muscle vibration. Repeated measures were collected and averaged

Population: Multiple sclerosis

ArmMeasureGroupValue (MEAN)Dispersion
Subject AToe ClearanceLeft leg volitional pre-training19.8 mmStandard Deviation 4.4
Subject AToe ClearanceRight Leg volitional pre-training17.6 mmStandard Deviation 4.4
Subject AToe ClearanceLeft leg volitional post-vibration training30.2 mmStandard Deviation 5.8
Subject AToe ClearanceRight volitional post-vibration training25.4 mmStandard Deviation 7.9
Subject BToe ClearanceRight volitional post-vibration training9.3 mmStandard Deviation 3.6
Subject BToe ClearanceLeft leg volitional pre-training30.6 mmStandard Deviation 7.8
Subject BToe ClearanceLeft leg volitional post-vibration training32 mmStandard Deviation 5.8
Subject BToe ClearanceRight Leg volitional pre-training9.1 mmStandard Deviation 2.5
Subject CToe ClearanceRight volitional post-vibration training24.7 mmStandard Deviation 4.7
Subject CToe ClearanceRight Leg volitional pre-training21.5 mmStandard Deviation 3.4
Subject CToe ClearanceLeft leg volitional post-vibration training25.5 mmStandard Deviation 3.6
Subject CToe ClearanceLeft leg volitional pre-training21.3 mmStandard Deviation 3.5
Primary

Walking Distance

Volitional walking distance at baseline and after gait training with vibration

Time frame: baseline and after twelve 1 hour sessions in four weeks of gait training with muscle vibration. Repeated measures were collected and averaged

ArmMeasureGroupValue (MEAN)Dispersion
Subject AWalking DistanceVolitional pre-training347 metersStandard Deviation 0
Subject AWalking DistanceVolitional post-vibration training361 metersStandard Deviation 12
Subject BWalking DistanceVolitional pre-training252 metersStandard Deviation 0
Subject BWalking DistanceVolitional post-vibration training387 metersStandard Deviation 11
Subject CWalking DistanceVolitional pre-training338 metersStandard Deviation 0
Subject CWalking DistanceVolitional post-vibration training406 metersStandard Deviation 0

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026